Session Details

[W3-1]Herpesvirus 2

Thu. Oct 31, 2019 3:00 PM - 4:00 PM JST
Thu. Oct 31, 2019 6:00 AM - 7:00 AM UTC
Room 1 Big Hall
Chair:
Akihisa Kato (Division of Viral Infection,Department of Infectious Disease Control,The Institute of Medical Science, The University of Tokyo)
Yasuko Mori (Divison of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine)

[W3-1-07]A novel fusion of the VZV latency-associated transcript and ORF63 facilitates reactivation

*Tomohiko Sadaoka1, Werner J. D. Ouwendijk2, Daniel P Depledge3, Labchan Rajbhandari4, Judith Breuer5, Georges M. G. M. Verjans2,6, Yasuko Mori1 (1. Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, 2. Department of Viroscience, Erasmus MC, 3. Department of Medicine, New York University School of Medicine, 4. Division of Neuroimmunology and Neuroinfectious Diseases, Department of Neurology, Johns Hopkins University School of Medicine, 5. MRC Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, 6. Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover)

[W3-1-08]Post-transcriptional regulation of human herpesvirus 6 immediate-early 1 and 2 genes by Immediate-Early 2 and splicing factor SART3

*Kazuya Shimada1, Nobuyuki Kobayashi1, Naomi Oka1, Mayumi Takahashi1, Kazuhiro Kondo1 (1. The Jikei University)

[W3-1-09]Analysis of newly identified host molecules inhibiting HHV-6A and -6B infection

*Tadahiro Suenaga1,2, Yasuko Mori3, Hisashi Arase1,2 (1. Research Institute for Microbial Diseases, Osaka University, 2. Immunology Frontier Research Center, Osaka University, 3. Kobe University)